Albumin Infusion Guidelines

Context-Specific Considerations

For spontaneous bacterial peritonitis, albumin should be given within 6 hours of diagnosis, with a dose of 1.5 g/kg, according to the European Association for the Study of the Liver guidelines 1, 2
After large-volume paracentesis, albumin is infused after the procedure is completed, at 8 g/L of ascites removed, as recommended by the European Association for the Study of the Liver guidelines 1, 2
Doses exceeding 87.5 g (>4×100 mL of 20% albumin) may be associated with worse outcomes due to fluid overload in cirrhosis patients, emphasizing the importance of monitoring during administration, with a strength of evidence based on retrospective studies 1, 2

Important Safety Considerations

Fluid overload is a documented complication of albumin administration in cirrhotic patients, particularly with higher doses or rapid administration, according to the European Association for the Study of the Liver guidelines 1, 2
Patients with increased or rising serum creatinine require careful monitoring during albumin infusion, as recommended by the European Association for the Study of the Liver guidelines 1, 2

Ongoing Research

In ongoing trials for septic shock and acute kidney injury, 100 mL doses of 20% or 25% albumin are being studied, with variable infusion times, as part of the trial protocols sponsored by the American Thoracic Society 3, 4
For cardiac surgery patients, one trial protocol specified that 20% albumin would be "administered on arrival in the ICU and continued for 15 hours," suggesting prolonged infusion for larger volumes, according to the American Thoracic Society guidelines 4

Albumin Dosing for Intravenous Administration

Cirrhosis-Specific Dosing

The American Association for the Study of Liver Diseases recommends administering 1.5 g/kg of albumin within 6 hours of diagnosis of spontaneous bacterial peritonitis, followed by 1.0 g/kg on day 3, which reduces kidney impairment and mortality in patients with cirrhosis 5
The administration of 8 g of albumin per liter of ascites removed after large-volume paracentesis is recommended, with studies evaluating 5-10 g/L removed, and 6-8 g/L appearing appropriate if albumin is used 6

Hypovolemic Shock and Burns

The International Collaboration for Transfusion Medicine Guidelines recommend against routine albumin use in adult critical care patients, including those with hypovolemic shock, unless there is active bleeding or other specific indications 7

Special Populations and Situations

The use of 25% albumin (25 g dose) given with each dialysis session improved hypotension and ultrafiltration in patients with serum albumin <30 g/L, but guidelines suggest against routine use given lack of definitive benefit over alternatives 8
The 2024 International Collaboration for Transfusion Medicine Guidelines explicitly recommend against routine albumin use in patients undergoing cardiovascular surgery, and in admitted patients with cirrhosis for treatment of hypoalbuminemia alone or extraperitoneal infections 7

When NOT to Use Albumin

The International Collaboration for Transfusion Medicine Guidelines recommend against routine albumin use in neonatal, pediatric, and adult critical care patients, including those with intradialytic hypotension, unless there is a specific indication 7

Albumin Administration Guidelines

Indications and Contraindications

The American Thoracic Society recommends that albumin should not be used routinely in most critically ill patients for volume replacement or to correct hypoalbuminemia, but is indicated for specific cirrhosis complications including large-volume paracentesis (>5L), spontaneous bacterial peritonitis, and hepatorenal syndrome 9, 10
Albumin prevents paracentesis-induced circulatory dysfunction in patients undergoing large-volume paracentesis (>5L) 9
The American College of Chest Physicians suggests that albumin is uniformly administered in treatment protocols for hepatorenal syndrome, though specific dosing varies 11
Albumin should not be used for first-line volume replacement in critically ill adults, excluding burns/ARDS, due to moderate to high quality evidence 9, 10
The American Thoracic Society recommends against using albumin for correcting hypoalbuminemia alone, thermal injuries or ARDS for volume replacement, and mobilizing extravascular fluid with diuretics 9

Safety Considerations

The FDA requires mandatory monitoring for circulatory overload during albumin administration, particularly in cirrhotic patients receiving higher doses or rapid administration 9
Hypotension, hemodilution requiring RBC transfusion, anaphylaxis, and peripheral gangrene from dilution of natural anticoagulants are documented complications of albumin administration 10

Cost Considerations

Albumin costs approximately $130 per 25g, making it substantially more expensive than crystalloids, which supports restricting use to well-defined indications 10
The high cost of albumin, combined with limited evidence of benefit in most settings, supports restricting use to well-defined indications, as recommended by the American College of Chest Physicians 9, 10

Albumin Infusion Guidelines

Introduction to Albumin Infusion

The International Collaboration for Transfusion Medicine Guidelines recommend against albumin use in first-line volume replacement in critically ill adults, excluding burns and ARDS, as well as correcting hypoalbuminemia alone without specific indication, routine use in cardiovascular surgery, intradialytic hypotension as routine therapy, and treatment of hypoalbuminemia in cirrhosis without specific complications, according to the 2024 guidelines 12

Economic Considerations

The use of albumin for intradialytic hypotension is not recommended due to its high cost, approximately $20,000 annually per patient, and lack of definitive superiority over alternatives, as stated by guidelines from a reputable medical society 13

Albumin Dosing Guidelines for Specific Indications

Indications for Albumin Use

The American Association for the Study of Liver Diseases recommends administering 8 g of albumin per liter of ascites removed after large-volume paracentesis (>5L) in patients with cirrhosis 14
The American Association for the Study of Liver Diseases suggests using 6-8 g/L of albumin regardless of volume removed in patients with acute-on-chronic liver failure (ACLF) 14
The American Association for the Study of Liver Diseases recommends giving 1.5 g/kg of albumin within 6 hours of diagnosis for spontaneous bacterial peritonitis (SBP) 14, 15
The American Association for the Study of Liver Diseases suggests following up with 1.0 g/kg of albumin on day 3 for SBP 14
The American Association for the Study of Liver Diseases recommends using albumin in conjunction with vasoconstrictors like terlipressin for hepatorenal syndrome (HRS-AKI) 15

Contraindications and Precautions

The International Collaboration for Transfusion Medicine Guidelines explicitly recommend against using albumin as first-line volume replacement in critically ill adults (excluding thermal injuries and ARDS) 16, 17
The International Collaboration for Transfusion Medicine Guidelines recommend against using albumin to correct hypoalbuminemia alone without specific complications 16
The International Collaboration for Transfusion Medicine Guidelines recommend against routine use of albumin in cardiovascular surgery 16
The International Collaboration for Transfusion Medicine Guidelines recommend against using albumin for uncomplicated ascites in cirrhosis 15

Documented Complications

Fluid overload and pulmonary edema are potential complications of albumin use 16
Hypotension is a potential complication of albumin use 16
Hemodilution requiring RBC transfusion is a potential complication of albumin use 16
Anaphylaxis is a potential complication of albumin use 16
Peripheral gangrene from dilution of natural anticoagulants is a potential complication of albumin use 16

Duration of Effect of IV Albumin

Pharmacokinetic Profile and Duration

The American Thoracic Society recommends that IV albumin is used for acute, time-limited indications like spontaneous bacterial peritonitis or post-paracentesis circulatory support, as its effect is transient, lasting hours to days, not weeks 18, 19

Clinical Dosing Schedules Reflect Short Duration

The International Ascites Club recommends dosing protocols of 1.5 g/kg within 6 hours of diagnosis, followed by 1.0 g/kg on day 3 for spontaneous bacterial peritonitis, indicating the initial dose effect has waned 18, 19, 20
The European Association for the Study of the Liver recommends 8 g albumin per liter of ascites removed, administered after paracentesis completion, as a single-dose intervention for acute prevention of paracentesis-induced circulatory dysfunction 20

Long-Term Albumin Administration Studies

The ANSWER study used weekly outpatient albumin infusions, demonstrating that continuous administration is required to maintain benefit 20, 21
The Gut journal recommends twice-weekly dosing for refractory ascites, showing benefits only with ongoing administration 20

Why Albumin Should NOT Be Used for Chronic Hypoalbuminemia

The 2024 International Collaboration for Transfusion Medicine Guidelines explicitly recommend against albumin use for treatment of hypoalbuminemia alone in cirrhosis or other conditions 21

Critical Pitfalls to Avoid

The European Association for the Study of the Liver warns that doses exceeding 87.5g may be associated with worse outcomes due to fluid overload in cirrhosis patients 20
The American Thoracic Society advises against using albumin for routine volume replacement in critically ill patients, as crystalloids are equally effective and far less expensive 18, 21

Albumin Administration Guidelines

Indications for Albumin Administration

The American Association for the Study of Liver Diseases recommends administering 8 g of albumin per liter of ascites removed after completing a large-volume paracentesis (>5L) 22
In patients with acute-on-chronic liver failure (ACLF), 6-8 g/L of albumin should be used, regardless of the volume removed 22
The American Association for the Study of Liver Diseases suggests that patients with spontaneous bacterial peritonitis (SBP) should receive a first dose of 1.5 g/kg of albumin within the first 6 hours of diagnosis, and a second dose of 1.0 g/kg on day 3 22
Patients with SBP who have higher bilirubin levels (>4 mg/dL) or renal impairment (creatinine >1.0 mg/dL and BUN >30 mg/dL) at diagnosis may benefit more from albumin administration 22
Albumin administration in SBP reduces the risk of acute kidney injury (10% vs 33%) and mortality (10% vs 29%) compared to antibiotics alone 22

Contraindications for Albumin Administration

The American Association for the Study of Liver Diseases recommends that albumin should not be used to correct low serum albumin levels in patients with cirrhosis, nephrotic syndrome, malabsorption, or malnutrition without specific complications 22
Albumin should not be administered to patients with uncomplicated ascites, as the standard treatment is sodium restriction and diuretics (spironolactone ± furosemide) 22
The American Association for the Study of Liver Diseases suggests that albumin should not be used in infections other than SBP, as it does not reduce the risk of acute kidney injury or mortality and may be associated with more pulmonary edema 22

Albumin 20% Administration Guidelines

Indications and Dosage

The American Thoracic Society recommends administering 8 g of albumin per liter of ascites removed in patients with large-volume paracentesis (>5L) 23
The American Thoracic Society suggests that albumin 20% should not be used for routine volume replacement in critically ill patients, as crystalloids are first-line, with a strength of evidence based on guidelines from Chest in 2024 and Anaesthesia in 2022 23, 24

Contraindications

The American Thoracic Society advises against using albumin 20% for correcting low serum albumin alone without specific complications, cardiovascular surgery, or chronic hypoalbuminemia from cirrhosis, nephrotic syndrome, or malnutrition without acute complications 23

Daily Albumin Administration in Fluid Overload with Hypotension and Hypoalbuminemia

Evidence Against Routine Albumin Use

The International Collaboration for Transfusion Medicine Guidelines explicitly recommend against using albumin to correct hypoalbuminemia alone in hospitalized patients, including those with cirrhosis, nephrotic syndrome, or critical illness 25

Critical Safety Concerns with Daily Albumin

Fluid overload and pulmonary edema are documented complications of albumin administration, particularly with repeated dosing or doses exceeding 87.5g 26, 27
Adding daily albumin to a patient with existing fluid overload will likely worsen this condition rather than improve it 26

Optimize Diuresis Without Albumin

The American Society of Nephrology recommends continuing furosemide at appropriate doses (0.5-2 mg/kg per dose, up to 6 times daily, maximum 10 mg/kg/day) based on fluid status and response 28
Consider adding a thiazide diuretic or amiloride for synergistic effect, as recommended by the National Kidney Foundation 28
Monitor closely for electrolyte abnormalities, blood pressure, kidney function, and fluid status, as advised by the European Renal Association 28

Specific Time-Limited Indications for Albumin

The American Association for the Study of Liver Diseases recommends using 8g albumin per liter of ascites removed after large-volume paracentesis (>5L) 26, 27
The Infectious Diseases Society of America recommends using 1.5 g/kg albumin within 6 hours of diagnosis of spontaneous bacterial peritonitis, followed by 1.0 g/kg on day 3 only 26, 27

Cost Considerations

The American College of Chest Physicians notes that daily albumin administration is extremely expensive ($3,900/month) without evidence of benefit 25

Safety Concerns and Contraindications for 20% Albumin Administration

Adverse Hemodynamic Effects

Paradoxical hypotension may occur during 20% albumin infusion, requiring close blood‑pressure monitoring. 29

Guideline Recommendations Against Routine Use

The 2024 International Collaboration for Transfusion Medicine Guidelines advise that 20% albumin should not be used for:

Evidence‑Based Use of Human Albumin 20 %

Approved Indications

Severe burns – In patients with a total body‑surface‑area burn > 30 % and after the first 6 hours of resuscitation, 20 % albumin should be given at 1–2 g/kg per day to target a serum albumin > 30 g/L. This recommendation is supported by strong evidence. 31

Contraindicated or Cautious Use

Routine volume replacement in critically ill patients – Crystalloid solutions are the first‑line choice; the use of 20 % albumin for routine volume expansion is not recommended. 32
Cardiac dysfunction – When albumin is considered in patients with underlying cardiac dysfunction, infusion must be accompanied by careful hemodynamic monitoring because of heightened risk of adverse events. 31
Volume expansion when alternatives exist – Guidelines advise opting for crystalloid fluids rather than 20 % albumin for volume expansion, reflecting a preference for safer, evidence‑based therapy. 32